Joseph Answine, MD
Anesthesiology · Mechanicsburg, PANPI 1205826674
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $169,844 of the $254,677 with a category attached, or 66.7%. 12 manufacturers reported payments, led by Merck at 49.2% of the total. Reporting peaked in 2019 at $143,930 and has fallen 99.7% since, to $491 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $899.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$125K
- Baxter Healthcare$65K
- Chiesi USA, Inc.$40K
- Trevena, Inc.$18K
- Acelrx Pharmaceuticals, Inc.$3K
- Baudax Bio Inc.$1K
- plus $1K from 6 others
What the payments were for
- Consulting fees$25,66310%
- Speaking & faculty fees$169,84467%
- Travel & lodging$44,81518%
- Food & beverage$5,0732%
- Education$9,2374%
- Gifts$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 139 | $125,348 |
| Baxter Healthcare | 49 | $65,202 |
| Chiesi USA, Inc. | 57 | $40,361 |
| Trevena, Inc. | 18 | $17,886 |
| Acelrx Pharmaceuticals, Inc. | 6 | $3,461 |
| Baudax Bio Inc. | 2 | $1,219 |
| BD | 1 | $450 |
| Mallinckrodt Enterprises LLC | 6 | $392 |
| Pacira Pharmaceuticals Incorporated | 1 | $153 |
| Heron Therapeutics, Inc. | 1 | $90 |
| Stryker | 2 | $75 |
| Mindray DS USA, Inc. | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRIDION$117,916
- SUPRANE$57,929
- CLEVIPREX$39,479
- Olinvyk$17,778
- IPS - Frozen Premix$4,928
- DSUVIA$3,442
- SEVOFLURANE$3,075
- DESFLURANE$1,600
- ANJESO$1,219
- OFIRMEV$216
- EXPAREL$153
- Non-Franchise (NOF) - NonProduct$125
How this compares
$254,677 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Verapamil ErVerapamil Hcl | 11 | $179 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Mechanicsburg
- Lee FleisherPhiladelphia$659K
- Eugene ViscusiPhiladelphia$398K
- Michael ScottPhiladelphia$250K
- William McIvorPittsburgh$226K
- Jonathan WatersPittsburgh$191K
- Nirmal ShahAllentown$85K
- Joshua AtkinsPhiladelphia$55K
- Sanjib AdhikaryHershey$47K
- Patrick FallAbington$41K
- Stephen BaderBeaver$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.